http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106420715-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-885 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10 |
| filingDate | 2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106420715-B |
| titleOfInvention | Mould enol E1 derived from tangerine green trichoderma is in the application for preparing anti-lymphadenoma drug |
| abstract | The present invention relates to a kind of mould enol E1 derived from tangerine green trichoderma in the application for preparing anti-lymphadenoma drug.The compound structure is characterized in: the molecular skeleton containing five cyclic amides, containing connecting on one ten carbon saturated fat long-chain of a carbonyl connection, N, a methyl, there are two hydroxyl groups for molecule.It is verified by experiments, the alkaloid compound has preferable inhibitory activity to lymthoma.It can be used as and prepare lymphoma cell Proliferation Ability drug or anti-lymphadenoma drug for antitumor research. |
| priorityDate | 2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.